Skip to content
Subscriber Only
Newsletter

Cannabis-Adjacent Deals Thrive in the U.S., Where Pot is Still Illegal

An employee inspects a flowering cannabis plant in a grow room at the Cilo Cybin Pharmaceutical Ltd. facility in Samrand, South Africa.

An employee inspects a flowering cannabis plant in a grow room at the Cilo Cybin Pharmaceutical Ltd. facility in Samrand, South Africa.

Photographer: Waldo Swiegers/Bloomberg
By

Hi it’s Liana in New York—I hope your 2022 is off to a decent start. Today, I’m looking at a deal related to the cannabis industry and breaking down why we haven’t seen more of these here in the U.S. Plus, details on the Fanatics/Topps deal and TPG’s IPO plans. 

Today's top stories

Deals related to the cannabis industry have been busy for the past few years, with major consolidation happening north of the border in my home country of Canada, which has also seen plenty of pot IPOs.